Author

Andrés M. Acosta-Moreno

Consejo Superior de Investigaciones CientíficasORCID 0009-0001-8152-0846Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Approach:machine learning (classical)· 1

Frequent Co-Authors

Almudena Méndez‐PéreziD· 1 shared Arrate Muñoz‐BarrutiaiD· 1 shared Carlos Óscar S. SorzanoiD· 1 shared Carlos Wert-CarvajaliD· 1 shared Esteban VeigaiD· 1 shared José Ramón MacíasiD· 1 shared Pilar Ballesteros-CuarteroiD· 1 shared Ramón AlemanyiD· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Almudena Méndez‐PérezORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ImmunologybioRxivNov 22, 2023

Unraveling the Power of NAP-CNB's Machine Learning-enhanced Tumor Neoantigen Prediction

Almudena Méndez‐Pérez, Andrés M. Acosta-Moreno, Carlos Wert-Carvajal…·Esteban Veiga

This study validates a machine learning platform, NAP-CNB, for identifying tumor neoantigens using RNAseq data, showing improved antitumor responses with multiantigen vaccination.

2 citations

humanbulk RNA-seq

𝕏 PostBluesky